Although acute toxicity was higher for ultra-hypofractionation than conventional fractionation, this long-term patient-reported QOL analysis shows that ultra-hypofractionation was as well tolerated as ...

Background: The prostatic anterior zone (AZ) is not targeted routinely by TRUS guided prostate biopsy (TRUS-Pbx). MRI is an accurate diagnostic tool for AZ tumors, but is often unavailable due to ...

Prostate and bladder cancer in men can be prevented with the right lifestyle practices. Around Father's Day 2025 is a good time to learn such tips. Monday, Jun 23, 2025. New Delhi o C.

In many cases, early-stage prostate cancer will not spread or cause any problems or side effects for a long time, if ever. That’s why your health care provider may suggest active surveillance. This is ...

10 Prostate Disease Center, Taichung Veterans General Hospital, Taichung, Taiwan. 11 Department of Urology, Temple University School of Medicine, Philadelphia, PA, USA.

Prostate Cancer Screening Ages 40 to 54 The PSA test is a blood test that measures how much of a particular protein (called prostate-specific antigen) is in your blood. It’s been the standard for ...

My dad had a bout with prostate cancer, which he won. "I’m 60. It’s something I’ve always been cognizant of, and my doctor and I talk about it every annual visit," he continued.

ESPN's SportsCenter anchor Jay Harris shared that he has been diagnosed with prostate cancer during an appearance on "Good Morning America." Sports newsletter 🏈's best, via 📧 Studio IX 🏀 ...

American Hospital Dubai sets a new standard for precision patient care in the region with the launch of the Focal One HIFU Robotic System, a groundbreaking non-invasive treatment for prostate cancer.

Although Men's Health Month highlights a wide range of health concerns, prostate cancer has recently drawn increased attention following former President Joe Biden's diagnosis. 1 On May 18, the ...

The drug significantly delayed time to metastatic castration-resistant prostate cancer (mCRPC; HR 0.40), PSA progression (HR, 0.31), and the need for subsequent systemic anticancer therapy (HR, 0.40).